 |
|
Christopher R. Burrow, MD Dr. Burrow, is the Humetrix Chief Medical Officer and has led the medical informatics and data analytics team at Humetrix throughout the development of the company's portfolio of digital health platforms. Dr. Burrow is the Clinical Safety and Data Protection Officer within the company and has been actively engaged in addressing safety, privacy and mobile health app security requirements in the US and in Europe. Prior to joining Humetrix, Dr. Burrow was VP Research & Medical Affairs at DNA Sciences with a leadership role in pharmacogenetics and the development of new genetic diagnostic tests for cardiovascular disease. Subsequently Dr. Burrow was an entrepreneur-in-residence at Kleiner Perkins involved in launching new ventures in the area of personalized medicine. Dr. Burrow trained in Internal Medicine, Nephrology and Molecular Biology at the Johns Hopkins University School of Medicine. As a faculty member first at Hopkins and then at the Mount Sinai School of Medicine, Dr. Burrow was an Attending Physician in Nephrology, and an NIH funded principal investigator whose research focused on the molecular basis of kidney organogenesis and genetic disorders of the kidney. |